Table of Contents

Articles

• You have access

  Regulation of Human CYP2C9 Expression by Electrophilic Stress Involves Activator Protein 1 Activation and DNA Looping

  Ngome L. Makia, Sailesh Surapureddi, Katalin Monostory, Russell A. Prough and Joyce A. Goldstein

  Molecular Pharmacology August 2014, 86 (2) 125-137; DOI: https://doi.org/10.1124/mol.114.092585
• You have access

  Label-Free Monitoring of μ-Opioid Receptor–Mediated Signaling

  Philippe Bourassa, Hanieh Bagheri Tudashki, Graciela Pineyro, Michel Grandbois and Louis Gendron

  Molecular Pharmacology August 2014, 86 (2) 138-149; DOI: https://doi.org/10.1124/mol.114.093450
• You have access

  RETRACTION: Angiotensin II and Canonical Transient Receptor Potential-6 Activation Stimulate Release of a Signal Transducer and Activator of Transcription 3–Activating Factor from Mouse Podocytes

  Mousa Abkhezr and Stuart E. Dryer

  Molecular Pharmacology August 2014, 86 (2) 150-158; DOI: https://doi.org/10.1124/mol.114.092536
• You have access

  Gating-Pore Currents Demonstrate Selective and Specific Modulation of Individual Sodium Channel Voltage-Sensors by Biological Toxins

  Yucheng Xiao, Kenneth Blumenthal and Theodore R. Cummins

  Molecular Pharmacology August 2014, 86 (2) 159-167; DOI: https://doi.org/10.1124/mol.114.092338
• You have access

  A Novel Pathway for Arsenic Elimination: Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Mediates Cellular Export of Dimethylarsinic Acid (DMA^V) and the Diglutathione Conjugate of Monomethylarsonous Acid (MMA^III)

  Mayukh Banerjee, Michael W. Carew, Barbara A. Roggenbeck, Brayden D. Whitlock, Hua Naranmandura, X. Chris Le and Elaine M. Leslie

  Molecular Pharmacology August 2014, 86 (2) 168-179; DOI: https://doi.org/10.1124/mol.113.091314
• You have access

  Molecular Mechanisms of Methoctramine Binding and Selectivity at Muscarinic Acetylcholine Receptors

  Jan Jakubík, Pavel Zimčík, Alena Randáková, Květoslava Fuksová, Esam E. El-Fakahany and Vladimír Doležal

  Molecular Pharmacology August 2014, 86 (2) 180-192; DOI: https://doi.org/10.1124/mol.114.093310
• You have access

  Poisoning of Mitochondrial Topoisomerase I by Lamellarin D

  Salim Khiati, Yeonee Seol, Keli Agama, Ilaria Dalla Rosa, Surbhi Agrawal, Katherine Fesen, Hongliang Zhang, Keir C. Neuman and Yves Pommier

  Molecular Pharmacology August 2014, 86 (2) 193-199; DOI: https://doi.org/10.1124/mol.114.092833
• You have access

  Complex Pharmacology of Novel Allosteric Free Fatty Acid 3 Receptor Ligands

  Brian D. Hudson, Elisabeth Christiansen, Hannah Murdoch, Laura Jenkins, Anders Højgaard Hansen, Ole Madsen, Trond Ulven and Graeme Milligan

  Molecular Pharmacology August 2014, 86 (2) 200-210; DOI: https://doi.org/10.1124/mol.114.093294
• You have access

  Long-Term Channel Block Is Required to Inhibit Cellular Transformation by Human Ether-à-Go-Go–Related Gene (hERG1) Potassium Channels

  David M. Pier, George S. G. Shehatou, Susan Giblett, Christine E. Pullar, Derek J. Trezise, Catrin A. Pritchard, R. A. John Challiss and John S. Mitcheson

  Molecular Pharmacology August 2014, 86 (2) 211-221; DOI: https://doi.org/10.1124/mol.113.091439
• You have access

  Modeling the Effects of β₁-Adrenergic Receptor Blockers and Polymorphisms on Cardiac Myocyte Ca²⁺ Handling

  Robert K. Amanfu and Jeffrey J. Saucerman

  Molecular Pharmacology August 2014, 86 (2) 222-230; DOI: https://doi.org/10.1124/mol.113.090951
• You have access

  Identification and Characterization of Novel Inhibitors of Mammalian Aspartyl Aminopeptidase

  Yuanyuan Chen, Hong Tang, William Seibel, Ruben Papoian, Ki Oh, Xiaoyu Li, Jianye Zhang, Marcin Golczak, Krzysztof Palczewski and Philip D. Kiser

  Molecular Pharmacology August 2014, 86 (2) 231-242; DOI: https://doi.org/10.1124/mol.114.093070